Hai Zheng Pharmaceutical (600267.SH) subsidiary Yiwimoji's active pharmaceutical ingredient is granted CEP certificate.

Zh tng cijng APP xn, hi zhng yoy (600267.SH) fb gnggo, jnr, gngs qunz zs hi zhng yoy hngzhu yuxin gngs (jinchng "hi zhng hngzhu gngs") shudo uzhu yopn zhling gunl j (European Directorate for the Quality of Medicines & HealthCare, yxi jinchng "EDQM") qinf de ywim x yunlioyo uzhu yodin shyng xng rnzhng zhngsh (Certificate of Suitability to Monograph of European Pharmacopoeia, yxi jinchng "CEP zhngsh"). The Zhitong Finance APP announces that Haizheng Pharma (600267.SH) recently received a Certificate of Suitability to Monograph of European Pharmacopoeia (CEP certificate) issued by the European Directorate for the Quality of Medicines & Healthcare (EDQM) for its subsidiary Haizheng Pharma Hangzhou Co., Ltd.